Ha habido 50 transacciones internas recientes registradas para FibroGen, Inc. (FGEN), incluyendo 21 compras y 27 ventas. El total de compras internas fue valorado en $2.43M y el total de ventas internas en $775.71K.
Internos destacados con actividad reciente incluyen Edwards Jeffrey L, Kauffman Michael, Schoeneck James A. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — FGEN
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-04 |
Edwards Jeffrey L |
Director |
Concesión de RSU |
120,000 |
$0.31 |
$36.61K |
120,000 |
| 2025-06-04 |
Kauffman Michael |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-04 |
Kauffman Michael |
Director |
Concesión de RSU |
70,000 |
$0.31 |
$21.36K |
70,000 |
| 2025-06-04 |
Schoeneck James A |
Director |
Concesión de RSU |
120,000 |
$0.31 |
$36.61K |
120,000 |
| 2025-06-04 |
Ho Maykin |
Director |
Concesión de RSU |
120,000 |
$0.31 |
$36.61K |
120,000 |
| 2025-03-24 |
Wettig Thane |
CEO |
Compra Informativa |
145,000 |
$0.35 |
$50.66K |
543,329 |
| 2025-03-21 |
Schoeneck James A |
Director |
Compra Informativa |
50,000 |
$0.34 |
$17.04K |
373,722 |
| 2025-03-20 |
Schoeneck James A |
Director |
Compra Informativa |
250,000 |
$0.35 |
$88K |
323,722 |
| 2025-03-06 |
Chung Christine |
SVP, China Operations |
Retención Fiscal de RSU |
7,008 |
$0.39 |
$2.73K |
294,544 |
| 2025-03-06 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
22,038 |
$0.39 |
$8.59K |
397,915 |
| 2025-03-06 |
Delucia David |
Chief Financial Officer |
Retención Fiscal de RSU |
2,325 |
$0.39 |
$906.75 |
116,137 |
| 2025-01-09 |
Wettig Thane |
CEO |
Concesión de RSU |
1,300,000 |
$0.65 |
$846.04K |
1,300,000 |
| 2025-01-09 |
Delucia David |
Chief Financial Officer |
Concesión de RSU |
525,000 |
$0.65 |
$341.67K |
525,000 |
| 2024-12-16 |
Delucia David |
Chief Financial Officer |
Desconocido |
44,000 |
$1.89 |
$83.16K |
- |
| 2024-12-07 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,066 |
$0.34 |
$364.68 |
164,863 |
| 2024-12-06 |
Chung Christine |
SVP, China Operations |
Retención Fiscal de RSU |
2,792 |
$0.34 |
$955.14 |
301,552 |
| 2024-12-06 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
2,363 |
$0.34 |
$808.38 |
419,953 |
| 2024-12-06 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,446 |
$0.34 |
$494.68 |
165,929 |
| 2024-09-07 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,065 |
$0.39 |
$415.35 |
167,375 |
| 2024-09-06 |
Chung Christine |
SVP, China Operations |
Retención Fiscal de RSU |
17,395 |
$0.39 |
$6.78K |
304,344 |
| 2024-09-06 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
2,363 |
$0.39 |
$921.57 |
422,316 |
| 2024-09-06 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
16,050 |
$0.39 |
$6.26K |
168,440 |
| 2024-08-01 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
20,840 |
$0.47 |
$9.79K |
424,679 |
| 2024-06-22 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
782 |
$1.13 |
$883.66 |
445,519 |
| 2024-06-12 |
Adib Deyaa |
Chief Medical Officer |
Compra Informativa |
22,123 |
$1.17 |
$25.88K |
82,123 |
| 2024-06-07 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,182 |
$1.10 |
$1.3K |
184,490 |
| 2024-06-06 |
Chung Christine |
SVP, China Operations |
Retención Fiscal de RSU |
19,289 |
$1.19 |
$22.95K |
321,739 |
| 2024-06-06 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
2,255 |
$1.19 |
$2.68K |
446,301 |
| 2024-06-06 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
17,797 |
$1.19 |
$21.18K |
185,672 |
| 2024-06-05 |
Edwards Jeffrey L |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Schoeneck James A |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Ho Maykin |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Brennan Aoife |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Lema Gerald |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Blaug Suzanne |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-06-05 |
Cravatt Benjamin |
Director |
Concesión de RSU |
70,000 |
$1.21 |
$84.7K |
70,000 |
| 2024-05-01 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
20,840 |
$1.17 |
$24.38K |
448,556 |
| 2024-04-22 |
Adib Deyaa |
Chief Medical Officer |
Disposición |
300,000 |
$1.71 |
$513K |
- |
| 2024-03-22 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
782 |
$2.58 |
$2.02K |
469,396 |
| 2024-03-07 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,181 |
$1.79 |
$2.11K |
203,469 |
| 2024-03-07 |
Wettig Thane |
CEO |
Compra Informativa |
50,000 |
$1.91 |
$95.47K |
470,178 |
| 2024-03-06 |
Chung Christine |
SVP, China Operations |
Retención Fiscal de RSU |
23,168 |
$1.87 |
$43.32K |
340,669 |
| 2024-03-06 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
4,209 |
$1.87 |
$7.87K |
419,723 |
| 2024-03-06 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
20,327 |
$1.87 |
$38.01K |
204,291 |
| 2024-02-21 |
Chung Christine |
SVP, China Operations |
Concesión de RSU |
143,000 |
$1.72 |
$245.25K |
143,000 |
| 2024-02-21 |
Wettig Thane |
CEO |
Concesión de RSU |
166,000 |
- |
- |
423,932 |
| 2024-02-21 |
Graham Juan |
Chief Financial Officer |
Concesión de RSU |
52,000 |
- |
- |
224,618 |
| 2024-02-01 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
23,490 |
$2.37 |
$55.67K |
257,932 |
| 2023-12-22 |
Wettig Thane |
CEO |
Retención Fiscal de RSU |
819 |
$0.76 |
$622.44 |
281,422 |
| 2023-12-07 |
Graham Juan |
Chief Financial Officer |
Retención Fiscal de RSU |
1,085 |
$0.62 |
$667.71 |
172,618 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
